We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

34 hedge funds and large institutions have $227M invested in Translate Bio, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$76.3M
2
OFM
Omega Fund Management
Massachusetts
+$29.5M
3
BG
Baupost Group
Massachusetts
+$23.2M
4
RSCM
Rock Springs Capital Management
Maryland
+$12.2M
5
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$11.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$73.4M +$76.3M +6,314,261 New
OFM
2
Omega Fund Management
Massachusetts
$30.8M +$29.5M +2,437,601 New
BG
3
Baupost Group
Massachusetts
$24.3M +$23.2M +1,923,076 New
RSCM
4
Rock Springs Capital Management
Maryland
$12.8M +$12.2M +1,011,079 New
BCPEM
5
Bain Capital Public Equity Management
Massachusetts
$12.3M +$11.8M +974,843 New
Federated Hermes
6
Federated Hermes
Pennsylvania
$8.98M +$8.58M +710,195 New
ACH
7
ArrowMark Colorado Holdings
Colorado
$8.72M +$8.33M +689,694 New
DM
8
Deerfield Management
New York
$8.22M +$7.86M +650,000 New
Citigroup
9
Citigroup
New York
$7.22M +$6.9M +571,000 New
AG
10
Artal Group
Luxembourg
$6.33M +$6.04M +500,000 New
PA
11
Perceptive Advisors
New York
$6.33M +$6.04M +500,000 New
CAM
12
Cormorant Asset Management
Massachusetts
$5.75M +$5.49M +454,550 New
FCM
13
Farallon Capital Management
California
$5.06M +$4.83M +400,000 New
LM
14
Luminus Management
Texas
$1.93M +$1.84M +152,163 New
BlackRock
15
BlackRock
New York
$1.9M +$1.81M +150,055 New
SFM
16
Sphera Funds Management
Israel
$1.65M +$1.57M +130,000 New
MIM
17
Monashee Investment Management
Massachusetts
$1.58M – – –
Wells Fargo
18
Wells Fargo
California
$1.39M +$1.33M +110,000 New
Millennium Management
19
Millennium Management
New York
$1.39M +$1.33M +109,651 New
Goldman Sachs
20
Goldman Sachs
New York
$1.18M +$1.13M +93,500 New
LCM
21
Laurion Capital Management
New York
$822K +$786K +65,000 New
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
$759K +$725K +60,000 New
KSCM
23
Key Square Capital Management
Connecticut
$696K +$665K +55,000 New
DIM
24
DC Investments Management
Virginia
$659K +$629K +52,084 New
UBS AM
25
UBS AM
Illinois
$524K +$500K +41,400 New
1
2

TBIO Hedge Fund Activity: Q2 2018 in Review

34 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q2 2018, worth a combined $227M.

Buyers outnumbered sellers: 34 funds opened new TBIO positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $76.3M.

  • 34 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $227M of Translate Bio, Inc. Common Stock stock for Q2 2018.
  • 34 funds opened new Translate Bio, Inc. Common Stock positions in Q2 2018 and 0 closed out, a net change of +34 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q2 2018 was Fidelity Investments, an estimated $76.3M added.

Based on aggregated 13F filings for Q2 2018.